Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee.

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...

Biohaven is powering ahead with its bold ambition to sharply reduce R&D spending—even as analysts warn the company will need to be even stricter with its expenditures. | Biohaven is powering ahead ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

The global obesity epidemic has become a major public health concern, prompting researchers to investigate the behavioral and biological factors that contribute to overeating. One important ...

Online posts claimed Gates donated $50 million to develop RNA-based technology for crops that U.S. regulators had supposedly ...

Jason Kelly, chief executive of Ginkgo Bioworks, spent a surprising amount of time on an earnings call with analysts last ...

Amid rising debate within the medical community, the US FDA has spoken out to defend how it reviews and authorizes new ...

In a groundbreaking experiment, researchers have achieved a remarkable feat that blurs the lines between biology and technology. Cortical Labs has cultivated 800K brain cells in a petri dish, ...

Therapeutic developers are increasingly rebuilding their workflows around AI to bring drugs to patients faster.

The congress opened with a plenary session that discussed and debated how to decode current disruptions seen in pharmaceutical markets globally.